Back to Treatments

Treatment

Tofersen (for SOD1-ALS)

1
Conditions
1
Trials
200
Participants
55%
Average Safety

Condition Evidence

Motor neuron disease

1 trials · 200 participants

60% effectiveness · 55% safety
Tofersen (for SOD1-ALS) | DFDA